![Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes | Endocrinology Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes | Endocrinology](https://www.frontiersin.org/files/MyHome%20Article%20Library/440649/440649_Thumb_400.jpg)
Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes | Endocrinology
![IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML](https://www.mdpi.com/ijerph/ijerph-16-02720/article_deploy/html/images/ijerph-16-02720-sch001.png)
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML
![Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats - ScienceDirect Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299916302096-gr6.jpg)
Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats - ScienceDirect
![Potential GLP-1 independent/dependent mechanisms of DPP-4 inhibition... | Download Scientific Diagram Potential GLP-1 independent/dependent mechanisms of DPP-4 inhibition... | Download Scientific Diagram](https://www.researchgate.net/publication/300412241/figure/fig5/AS:866940318928900@1583706087902/Potential-GLP-1-independent-dependent-mechanisms-of-DPP-4-inhibition-with-saxagliptin-in_Q320.jpg)
Potential GLP-1 independent/dependent mechanisms of DPP-4 inhibition... | Download Scientific Diagram
![Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways - ScienceDirect Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0014299919305722-fx1.jpg)
Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways - ScienceDirect
![Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41581-020-00367-2/MediaObjects/41581_2020_367_Fig1_HTML.png)
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology
![Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram](https://www.researchgate.net/profile/Sridhara-Janardhan-3/publication/260680847/figure/fig3/AS:513088665001985@1499341278619/Fig-3-Mechanism-of-action-for-GIP-GLP-1-analogues-and-DPP4-inhibitors-in-controlling.png)
Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram
![Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus - Fang - Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus - Fang -](https://onlinelibrary.wiley.com/cms/asset/fc9ab568-642c-42ee-8930-d0f6b4ee722d/jdi13224-fig-0001-m.jpg)
Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus - Fang -
![Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications - ScienceDirect Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177918300416-fx1.jpg)
Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications - ScienceDirect
![Frontiers | DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs | Immunology Frontiers | DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs | Immunology](https://www.frontiersin.org/files/MyHome%20Article%20Library/414233/414233_Thumb_400.jpg)
Frontiers | DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs | Immunology
![The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-018-0704-1/MediaObjects/12933_2018_704_Fig2_HTML.gif)
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text
![Supplemental Materials for Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial - Diabetes Research and Clinical Practice Supplemental Materials for Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial - Diabetes Research and Clinical Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1065769e-8cb7-47b8-a891-5853bb75d653/gr1_lrg.jpg)